Search Results - Lomaga, M

  • Showing 1 - 8 results of 8
Refine Results
  1. 1
    TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling

    TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling by Lomaga, M A, Yeh, W C, Sarosi, I, Duncan, G S, Furlonger, C, Ho, A, Morony, S, Capparelli, C, Van, G, Kaufman, S, van der Heiden, A, Itie, A, Wakeham, A, Khoo, W, Sasaki, T, Cao, Z, Penninger, J M, Paige, C J, Lacey, D L, Dunstan, C R, Boyle, W J, Goeddel, D V, Mak, T W

    Published in Genes & development
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Tumor Necrosis Factor Receptor-Associated Factor 6 (TRAF6) Deficiency Results in Exencephaly and Is Required for Apoptosis within the Developing CNS

    Tumor Necrosis Factor Receptor-Associated Factor 6 (TRAF6) Deficiency Results in Exencephaly and Is Required for Apoptosis within the Developing CNS by Lomaga, Mark A, Henderson, Jeffrey T, Elia, Andrew J, Robertson, Jennifer, Noyce, Ryan S, Yeh, Wen-Chen, Mak, Tak W

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    An Analysis of Patient-reported Outcomes in IXORA-S: Comparing Ixekizumab and Ustekinumab over 52 Weeks in Moderate-to-severe Psoriasis

    An Analysis of Patient-reported Outcomes in IXORA-S: Comparing Ixekizumab and Ustekinumab over 52 Weeks in Moderate-to-severe Psoriasis by Puig, L, Lomaga, M, Hollister, K, Dutronc, Y, Berggren, L, Kerkhof, P

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling

    TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling by Lomaga, M. A., Yeh, W.-C., Sarosi, I., Duncan, G. S., Furlonger, C., Ho, A., Morony, S., Capparelli, C., Van, G., Kaufman, S., van der Heiden, A., Itie, A., Wakeham, A., Khoo, W., Sasaki, T., Cao, Z., Penninger, J. M., Paige, C. J., Lacey, D. L., Dunstan, C. R., Boyle, W. J., Goeddel, D. V., Mak, T. W.

    Published in Genes & development
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  5. 5
    Geologic implications of the relationship between mammalian faunal similarity and geographic distance

    Geologic implications of the relationship between mammalian faunal similarity and geographic distance by Flessa, K. W, Barnett, S. G, Cornue, D. B, Lomaga, M. A, Lombardi, N, Miyazaki, J. M, Murer, A. S

    Published in Geology (Boulder)
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Geologic implications of the relationship between mammalian faunal similarity and geographic distance

    Geologic implications of the relationship between mammalian faunal similarity and geographic distance by Flessa, Karl W, Barnett, Stockton G, Cornue, David B, Lomaga, M A, Lombardi, N, Miyazaki, J M, Murer, Anthony S

    Published in Geology (Boulder)
    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    Effect of Roflumilast Cream vs Vehicle Cream on Chronic Plaque Psoriasis: The DERMIS-1 and DERMIS-2 Randomized Clinical Trials

    Effect of Roflumilast Cream vs Vehicle Cream on Chronic Plaque Psoriasis: The DERMIS-1 and DERMIS-2 Randomized Clinical Trials by Lebwohl, Mark G, Kircik, Leon H, Moore, Angela Y, Stein Gold, Linda, Draelos, Zoe D, Gooderham, Melinda J, Papp, Kim A, Bagel, Jerry, Bhatia, Neal, Del Rosso, James Q, Ferris, Laura K, Green, Lawrence J, Hebert, Adelaide A, Jones, Terry, Kempers, Steven E, Pariser, David M, Yamauchi, Paul S, Zirwas, Matthew, Albrecht, Lorne, Devani, Alim R, Lomaga, Mark, Feng, Amy, Snyder, Scott, Burnett, Patrick, Higham, Robert C, Berk, David R

    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:
  8. 8
    Bimekizumab Efficacy and Safety Over 48 Weeks in US and Canadian Patients with Psoriasis who had a Treatment Interruption After 3 Years of Treatment: Results from BE RADIANT

    Bimekizumab Efficacy and Safety Over 48 Weeks in US and Canadian Patients with Psoriasis who had a Treatment Interruption After 3 Years of Treatment: Results from BE RADIANT by Lebwohl, Mark, Papp, Kim, Ehst, Benjamin, Lomaga, Mark, Rich, Phoebe, Strober, Bruce, Armstrong, April, López Pinto, José M., Kaspar, Markus, Deherder, Delphine, Wang, Maggie, Vender, Ronald

    Published in Skin (Milwood, N.Y.)
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: